Table 3. Comparison of Mean Scores for Provider- and Patient-level Outcomes by Randomization Arm
Provider- and Patient-Level MeasuresIntervention* Mean or Proportion (SD) n = 85Control Mean or Proportion (SD) (n = 86)P ValueAdjusted Odds Ratio or Cohen's d** (95% CI)
Summary MI performance
    Rate of MI-consistent statements8.80 (4.16)6.98 (4.14).005d = 0.44 (0.13–0.74)
Summary global rating
    Beginning spirit in MI Spirit (≥3.5)0.37 (1.01)0.15 (0.59).0833.28 (0.83–12.90)
Provider treatment advice
    Recommendation for physical activity0.34 (0.54)0.19 (0.43).0532.21 (0.99–4.95)
    Prescription for antidepressant medication0.42 (0.53)0.38 (0.51).661.17 (0.59–2.30)
Frequency of patient change talk
    Rate of all depression treatment-related change talk0.90 (0.91)0.44 (0.90).001d = 0.51 (0.21–0.82)
    Rate of change talk specific to physical activity0.30 (0.51)0.10 (0.51).01d = 0.39 (0.09–0.70)
    Rate of change talk specific to antidepressant medication0.25 (0.47)0.15 (0.46).17d = 0.21 (−0.09 to 0.51)
Treatment adherence
    Days physically active in past week,§ n3.05 (2.83)1.84 (2.75).007d = 0.42 (0.11–0.72)
    Filled prescription, %0.62 (0.17)0.56 (0.17).631.27 (0.48–3.34)
  • Data are number (%) of participants unless stated otherwise.

  • * Motivational interviewing (MI) with standard management of depression training.

  • Standard management of depression training alone.

  • Mean rate of open questions, reflective statements, or MI-adherent statements per 10 minutes of the clinical encounter.

  • § Physical activity was ascertained on average 5.4 days (standard deviation, 3.3 days) after the index encounter.

  • Includes change talk regarding physical activity, antidepressant medication, specialty mental health counseling, and nonharmful behaviors the patient suggests might alleviate depressive symptoms.

  • Days in the previous week during which patient engaged in at least 30 minutes of physical activity.

  • ** Clinical effect sizes based on Cohen d values: 0.2, small; 0.5, medium; 0.8, large. Clinical effect sizes based on odds ratio (OR): 1.29, small; 1.88, medium; 2.79, large.44